About Advance Agrolife
Advance Agrolife is a publicly listed company based in Jaipur (India). It delivers comprehensive solutions for farm biologicals. It operates on a B2B model. The company has 141 employees. Its Indian entity Advance Agrolife Limited reported revenue of βΉ642 Cr. Its focus areas include Agribusiness, Biologicals and Farm Solutions. Its competitors include IPL Biologicals, Titan Biotech and Univia; 2 of its 3 listed competitors have raised funding.
Company details
Advance Agrolife delivers comprehensive solutions for farm biologicals through engaging in agricultural activities, agribusiness, biologicals, and farm solutions. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Jaipur, India
- Employees 141
- Stage Public
- SectorsAgriculture
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website advanceagrolife.com
- Social LinkedIn Facebook Instagram
- Legal Name Advance Agrolife Ltd.
- Market Cap₹845 Cr
ADVANCE · NSE
- Share Price₹135.05
+2.69% today
- Revenue₹502 Cr
FY 2024-25 · +10.2% YoY
- EBITDA₹49.28 Cr
Margin 9.8%
- Net Profit₹25.65 Cr
FY 2024-25 · +3.8% YoY
- P/E (TTM)34.2x
P/B 3.0x
- ROE29.1%
ROCE 27.9%
- Debt / Equity0.71
Interest cover 17.0x
- Employee Count141
Associated legal entities of Advance Agrolife
Advance Agrolife is associated with 2 registered companies on The Company Check; the primary company is Advance Agrolife Limited, a listed company. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Advance Agrolife Limited Listed CIN L24121RJ2002PLC017467 | Active | 27 Feb 2002 | Jaipur, Rajasthan | ₹642 Cr | 141 | 9 | View details |
| Advance Agrolife Limited CIN U24121RJ2002PLC017467 | 27 Feb 2002 | Jaipur, Rajasthan, India | View details |
Board of directors of Advance Agrolife Limited (Advance Agrolife)
Advance Agrolife Limited is the primary company behind Advance Agrolife. The board of Advance Agrolife Limited currently have 7 directors; the longest-serving is Om Prakash Choudhary, appointed in 2005. 11 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Om Prakash Choudhary DIN 01004122 | Managing Director | 29 Nov 2005 | 20 yrs 10 mo | Advance Agrolife Limited |
| Kedar Choudhary DIN 06905752 | Whole-time director | 25 Jan 2016 | 10 yrs 9 mo | Advance Agrolife Limited |
| Narendra Choudhary DIN 10410584 | Whole-time director | 30 Nov 2023 | 2 yrs 10 mo | Advance Agrolife Limited |
| Manjit Singh Kochar DIN 08298764 | Director | 05 Nov 2024 | 1 yr 11 mo | Advance Agrolife Limited |
| Rakesh Verma DIN 02242428 | Director | 13 Feb 2025 | 1 yr 8 mo | Advance Agrolife Limited |
| Seema Singh DIN 10042852 | Director | 13 Feb 2025 | 1 yr 8 mo | Advance Agrolife Limited |
| Brijmohan Sharma DIN 09646943 | Director | 06 Aug 2026 | 2 mo | Advance Agrolife Limited |
People of Advance Agrolife
1 people are tracked at Advance Agrolife (1 in leadership); the tracked headcount is 141.
| Name | Role | Group |
|---|---|---|
| Chairman and Managing Director | Leadership |
Complete people profiles for Advance Agrolife
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Advance Agrolife
Advance Agrolife is a publicly listed company on the NSE with ticker symbol ADVANCE in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date08 Oct 2025
- Listed onBSE: 544562 · NSE: ADVANCE
- Listed entityAdvance Agrolife Ltd.
- Exchange sectorProcess industries
- ISININE1B0W01010
- Share price₹155.67 (+8.13% on the day) · 2026-10-14
- Market capitalisation₹930 Cr
- Price to earnings20.5
- EPS (diluted, trailing year)₹7.60
- Volume (last session)8,853,759
Financials of Advance Agrolife
Exchange-reported figures of Advance Agrolife Limited, the listed company behind Advance Agrolife (NSE: ADVANCE).
Financial Highlights
FY 2024-25 Β· ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Income statement | ||
| Revenue | 502 | 456 |
| Revenue growth | +10.2% | - |
| EBITDA | 49.28 | 39.59 |
| EBITDA margin | +9.8% | +8.7% |
| Profit before tax | 35.21 | 33.28 |
| Net profit | 25.65 | 24.71 |
| Net profit margin | +5.1% | +5.4% |
| EPS (βΉ) | 5.70 | 54.96 |
| Balance sheet | ||
| Total assets | 182 | 121 |
| Net worth | 101 | 75.26 |
| Total debt | 80.45 | 45.46 |
| Cash & bank | 1.92 | 0.92 |
| Net working capital | 103 | 69.39 |
| Cash flow | ||
| Cash from operations | 5.71 | 14.84 |
| Cash from investing | (33.87) | (31.08) |
| Cash from financing | 28.28 | 16.63 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | 638 | 502 | 456 | 398 | 251 | 206 |
| Revenue growth | +27.0% | +10.2% | +14.6% | +58.7% | +22.0% | - |
| EBITDA | 64.70 | 49.27 | 39.59 | 25.49 | 14.70 | 16.01 |
| EBITDA margin | +10.1% | +9.8% | +8.7% | +6.4% | +5.9% | +7.8% |
| Profit before tax | 48.13 | 35.20 | 33.28 | 20.12 | 12.42 | 12.37 |
| Net profit | 35.31 | 25.64 | 24.71 | 14.87 | 9.00 | 9.07 |
| Net profit margin | +5.5% | +5.1% | +5.4% | +3.7% | +3.6% | +4.4% |
| EPS (βΉ) | 5.49 | 5.70 | 54.96 | 33.04 | 19.98 | 20.10 |
| Balance sheet | ||||||
| Total assets | 409 | 182 | 121 | 76.21 | 57.20 | 42.89 |
| Net worth | 310 | 101 | 75.26 | 50.60 | 35.70 | 26.91 |
| Total debt | 97.90 | 80.45 | 45.46 | 25.29 | 21.20 | 15.75 |
| Cash & bank | 75.13 | 1.92 | 0.92 | 0.07 | 0.47 | 0.21 |
| Net working capital | 278 | 103 | 69.39 | 52.64 | 39.39 | 27.14 |
| Cash flow | ||||||
| Cash from operations | (70.04) | 5.71 | 14.84 | 6.17 | (0.14) | 7.94 |
| Cash from investing | (108) | (33.87) | (31.08) | (8.01) | (3.24) | (5.69) |
| Cash from financing | 183 | 28.28 | 16.63 | 1.44 | 3.64 | (2.08) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 330 | 124 | 133 | 213 | 169 | 89.83 | 113 | 167 |
| Revenue growth (YoY) | +95.9% | +37.9% | +17.2% | +27.0% | +27.9% | - | - | - |
| Other income | 0.22 | 2.03 | 1.16 | 0.23 | 0.11 | 0.26 | 0.22 | 0.00 |
| Total expenses | 295 | 110 | 125 | 187 | 152 | 83.95 | 107 | 144 |
| EBITDA | 35.06 | 13.38 | 7.36 | 25.78 | 17.11 | 5.88 | 6.33 | 22.94 |
| EBITDA margin | +10.6% | +10.8% | +5.5% | +12.1% | +10.1% | +6.5% | +5.6% | +13.7% |
| Depreciation | 3.01 | 2.94 | 2.81 | 2.65 | 2.49 | 2.24 | 1.99 | 1.86 |
| Interest | 2.03 | 2.46 | 1.43 | 2.16 | 2.11 | 1.94 | 1.23 | 1.14 |
| Profit before tax | 30.24 | 10.01 | 4.28 | 21.20 | 12.62 | 1.96 | 3.33 | 19.94 |
| Tax | 7.69 | 2.55 | 1.27 | 5.32 | 3.69 | 0.54 | 0.55 | 5.74 |
Financial Statements
| Particulars | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Revenue | 502 | 456 |
| Revenue growth | +10.2% | - |
| Other income | 0.62 | 1.31 |
| Total expenses | 453 | 416 |
| Employee cost | 11.31 | 9.41 |
| EBITDA | 49.28 | 39.59 |
| EBITDA margin | +9.8% | +8.7% |
| Depreciation | 7.61 | 3.39 |
| Interest | 7.08 | 4.23 |
| Profit before tax | 35.21 | 33.28 |
| Tax | 9.56 | 8.56 |
| Net profit | 25.65 | 24.71 |
| Net profit margin | +5.1% | +5.4% |
| EPS (βΉ) | 5.70 | 54.96 |
| Particulars | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Equity & liabilities | ||
| Share capital | 45.00 | 4.50 |
| Reserves & surplus | 55.87 | 70.76 |
| Shareholders' funds (net worth) | 101 | 75.26 |
| Minority interest | 0.00 | 0.00 |
| Secured loans | 79.24 | 45.39 |
| Unsecured loans | 1.21 | 0.07 |
| Total debt | 80.45 | 45.46 |
| Total liabilities | 182 | 121 |
| Assets | ||
| Gross block | 88.39 | 55.10 |
| Net block | 65.89 | 40.21 |
| Capital work in progress | 11.00 | 9.43 |
| Investments | 0.00 | 0.00 |
| Inventories | 87.61 | 48.90 |
| Sundry debtors | 163 | 143 |
| Cash & bank balances | 1.92 | 0.92 |
| Loans & advances | 19.87 | 14.78 |
| Total current assets | 272 | 208 |
| Total current liabilities | 170 | 138 |
| Net working capital | 103 | 69.39 |
| Total assets | 182 | 121 |
| Particulars | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Opening cash | 0.46 | 0.07 |
| Net cash from operating activities | 5.71 | 14.84 |
| Net cash from investing activities | (33.87) | (31.08) |
| Net cash from financing activities | 28.28 | 16.63 |
| Net change in cash | 0.12 | 0.39 |
| Closing cash | 1.92 | 0.92 |
| Particulars | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Growth | ||
| Sales growth | +10.2% | - |
| EBITDA growth | +24.5% | - |
| PBT growth | +5.8% | +9997.0% |
| Net income growth | +3.8% | - |
| Profitability & leverage | ||
| Net income margin | +5.1% | +5.4% |
| Return on capital employed | +27.9% | +31.0% |
| Return on net worth | +29.1% | +32.9% |
| Debt / equity | 0.71 | 0.60 |
| Long-term debt / equity | 0.16 | 0.19 |
| Interest cover | 16.99 | 11.69 |
| Efficiency & per share | ||
| Fixed asset turnover | 7.00 | 8.27 |
| Inventory turnover | 7.36 | 9.32 |
| Debtors turnover | 3.28 | 3.18 |
| EPS (βΉ) | 5.70 | 54.96 |
| Dividend per share (βΉ) | 0.00 | 0.00 |
| Book value per share (βΉ) | 22.42 | 167.25 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 330 | 124 | 133 | 213 | 169 | 89.83 | 113 | 167 |
| Revenue growth (YoY) | +95.9% | +37.9% | +17.2% | +27.0% | +27.9% | - | - | - |
| Other income | 0.22 | 2.03 | 1.16 | 0.23 | 0.11 | 0.26 | 0.22 | 0.00 |
| Total expenses | 295 | 110 | 125 | 187 | 152 | 83.95 | 107 | 144 |
| EBITDA | 35.06 | 13.38 | 7.36 | 25.78 | 17.11 | 5.88 | 6.33 | 22.94 |
| EBITDA margin | +10.6% | +10.8% | +5.5% | +12.1% | +10.1% | +6.5% | +5.6% | +13.7% |
| Depreciation | 3.01 | 2.94 | 2.81 | 2.65 | 2.49 | 2.24 | 1.99 | 1.86 |
| Interest | 2.03 | 2.46 | 1.43 | 2.16 | 2.11 | 1.94 | 1.23 | 1.14 |
| Profit before tax | 30.24 | 10.01 | 4.28 | 21.20 | 12.62 | 1.96 | 3.33 | 19.94 |
| Tax | 7.69 | 2.55 | 1.27 | 5.32 | 3.69 | 0.54 | 0.55 | 5.74 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Revenue | 638 | 502 | 456 | 398 | 251 | 206 |
| Revenue growth | +27.0% | +10.2% | +14.6% | +58.7% | +22.0% | - |
| Other income | 3.98 | 0.62 | 1.31 | 0.17 | 2.09 | 0.03 |
| Total expenses | 573 | 453 | 416 | 372 | 236 | 190 |
| Employee cost | 15.04 | 11.31 | 9.41 | 6.68 | 5.16 | 6.72 |
| EBITDA | 64.70 | 49.27 | 39.59 | 25.49 | 14.70 | 16.01 |
| EBITDA margin | +10.1% | +9.8% | +8.7% | +6.4% | +5.9% | +7.8% |
| Depreciation | 10.88 | 7.61 | 3.39 | 2.46 | 1.97 | 1.81 |
| Interest | 9.67 | 7.08 | 4.23 | 3.08 | 2.40 | 1.86 |
| Profit before tax | 48.13 | 35.20 | 33.28 | 20.12 | 12.42 | 12.37 |
| Tax | 12.82 | 9.56 | 8.56 | 5.25 | 3.42 | 3.31 |
| Net profit | 35.31 | 25.64 | 24.71 | 14.87 | 9.00 | 9.07 |
| Net profit margin | +5.5% | +5.1% | +5.4% | +3.7% | +3.6% | +4.4% |
| EPS (βΉ) | 5.49 | 5.70 | 54.96 | 33.04 | 19.98 | 20.10 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Equity & liabilities | ||||||
| Share capital | 64.29 | 45.00 | 4.50 | 4.50 | 4.50 | 4.50 |
| Reserves & surplus | 246 | 55.87 | 70.76 | 46.10 | 31.20 | 22.41 |
| Shareholders' funds (net worth) | 310 | 101 | 75.26 | 50.60 | 35.70 | 26.91 |
| Secured loans | 96.06 | 79.24 | 45.39 | 25.15 | 21.03 | 12.06 |
| Unsecured loans | 1.84 | 1.21 | 0.07 | 0.14 | 0.17 | 3.69 |
| Total debt | 97.90 | 80.45 | 45.46 | 25.29 | 21.20 | 15.75 |
| Total liabilities | 409 | 182 | 121 | 76.21 | 57.20 | 42.89 |
| Assets | ||||||
| Gross block | 116 | 88.38 | 55.10 | 34.21 | 26.19 | 22.99 |
| Net block | 82.91 | 65.88 | 40.21 | 22.72 | 17.13 | 15.85 |
| Capital work in progress | 22.22 | 11.00 | 9.43 | 0.15 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 205 | 87.61 | 48.90 | 38.81 | 29.55 | 21.06 |
| Sundry debtors | 196 | 163 | 143 | 104 | 66.02 | 45.98 |
| Cash & bank balances | 75.13 | 1.92 | 0.92 | 0.07 | 0.47 | 0.21 |
| Loans & advances | 17.78 | 19.87 | 14.78 | 12.54 | 5.04 | 2.70 |
| Total current assets | 494 | 272 | 208 | 156 | 101 | 69.95 |
| Total current liabilities | 216 | 170 | 138 | 103 | 61.69 | 42.81 |
| Net working capital | 278 | 103 | 69.39 | 52.64 | 39.39 | 27.14 |
| Total assets | 409 | 182 | 121 | 76.21 | 57.20 | 42.89 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Opening cash | 0.58 | 0.46 | 0.07 | 0.47 | 0.21 | 0.04 |
| Net cash from operating activities | (70.04) | 5.71 | 14.84 | 6.17 | (0.14) | 7.94 |
| Net cash from investing activities | (108) | (33.87) | (31.08) | (8.01) | (3.24) | (5.69) |
| Net cash from financing activities | 183 | 28.28 | 16.63 | 1.44 | 3.64 | (2.08) |
| Net change in cash | 4.88 | 0.12 | 0.39 | (0.40) | 0.26 | 0.17 |
| Closing cash | 75.13 | 1.92 | 0.92 | 0.07 | 0.47 | 0.21 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Growth | ||||||
| Sales growth | +27.0% | +10.2% | +14.6% | +58.7% | +22.0% | - |
| EBITDA growth | +31.3% | +24.5% | +55.3% | +73.4% | -8.2% | - |
| PBT growth | +36.7% | +5.8% | +65.4% | +62.0% | +0.4% | +9997.0% |
| Net income growth | +37.7% | +3.8% | +66.2% | +65.2% | -0.8% | - |
| Revenue CAGR (3Y) | +17.0% | +26.1% | +30.4% | - | - | - |
| EBITDA CAGR (3Y) | +36.4% | +49.7% | +35.2% | - | - | - |
| Profitability & leverage | ||||||
| Net income margin | +5.5% | +5.1% | +5.4% | +3.7% | +3.6% | +4.4% |
| Return on capital employed | +19.6% | +27.9% | +38.0% | +34.8% | +29.6% | +33.1% |
| Return on net worth | +17.2% | +29.1% | +39.3% | +34.5% | +28.7% | +33.6% |
| Debt / equity | 0.43 | 0.71 | 0.56 | 0.54 | 0.59 | 0.59 |
| Long-term debt / equity | 0.08 | 0.16 | 0.16 | 0.11 | 0.16 | 0.25 |
| Interest cover | 17.97 | 16.99 | 11.69 | 13.37 | 18.85 | 13.10 |
| Efficiency & per share | ||||||
| Fixed asset turnover | 6.23 | 7.00 | 10.21 | 13.17 | 10.20 | 8.94 |
| Inventory turnover | 4.36 | 7.36 | 10.40 | 11.64 | 9.91 | 9.76 |
| Debtors turnover | 3.55 | 3.28 | 3.68 | 4.67 | 4.48 | 4.47 |
| EPS (βΉ) | 5.49 | 5.70 | 54.96 | 33.04 | 19.98 | 20.10 |
| Dividend per share (βΉ) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (βΉ) | 48.21 | 22.42 | 167.25 | 112.44 | 79.34 | 59.79 |
Competitors of Advance Agrolife
Advance Agrolife has 3 listed competitors in our database, 2 of them funded. They include IPL Biologicals, Titan Biotech and Univia.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| iplbiologicals.com | 1994 | Gurugram, India | $4.66M | 901 | Plant nutrition and protection products are manufactured and supplied. | |
| titanbiotechltd.com | 1992 | Delhi, India | 406 | Biological products are manufactured and exported for various industries. | ||
| univia.in | 2020 | Ahmedabad, India | $237,838 | 52 | Agri-input retailers are connected to farmers via a phygital network. |
Detailed competitors of Advance Agrolife
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Crop Farming & Production
2 companies that operate in the same segment as Advance Agrolife (Crop Farming & Production) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Diverse products in FMCG, hotels, packaging, and agri-business are offered. | 1910 | Kolkata, West Bengal, India | USD 8.78 B | 47,360 | ||
Cooperative organization for milk production, animal health, and dairy services in India. | 1946 | Anand, Gujarat, India | USD 44.2 M | 571 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Advance Agrolife
Complete news archive for Advance Agrolife
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Advance Agrolife
Advance Agrolife is headquartered in Jaipur, India. It is registered at Jaipur, Rajasthan, India.
Advance Agrolife has 141 employees.
The primary company behind Advance Agrolife, Advance Agrolife Limited, reported revenue of βΉ642 Cr for FY 2026, up 27% year on year.
Advance Agrolife delivers comprehensive solutions for farm biologicals through engaging in agricultural activities, agribusiness, biologicals, and farm solutions. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Advance Agrolife's top competitors include Titan Biotech, IPL Biologicals and Univia.
Yes, Advance Agrolife is publicly traded on NSE under the ticker symbol ADVANCE.
Advance Agrolife operates through Advance Agrolife Limited.
The legal entities of Advance Agrolife currently have 9 directors, including Om Prakash Choudhary, Kedar Choudhary, Rakesh Verma and others.

